Welcome to LookChem.com Sign In|Join Free
  • or
4-Chlorophenyl chloroformate is an organic compound that serves as a valuable chemical intermediate and research reagent. It is characterized by its ability to form reactive intermediates and participate in various chemical reactions, making it a versatile component in the synthesis of different organic compounds.

7693-45-0

Post Buying Request

7693-45-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7693-45-0 Usage

Uses

Used in Chemical Synthesis:
4-Chlorophenyl chloroformate is used as a chemical intermediate for the synthesis of various organic compounds. Its reactivity allows it to participate in a range of chemical reactions, facilitating the formation of desired products.
Used in Research Purposes:
In the field of research, 4-Chlorophenyl chloroformate is employed as a reagent to explore new chemical reactions and investigate the properties of different organic compounds. Its versatility makes it a valuable tool for advancing scientific knowledge.
Used in Pharmaceutical Industry:
4-Chlorophenyl chloroformate is used as a key intermediate in the preparation of N-hydroxy-N-methylcarbamate 4-chlorophenyl ester, which is an important compound in the development of pharmaceuticals. Its role in the synthesis of this ester highlights its significance in the creation of new drugs and therapeutic agents.
Used in Agrochemical Industry:
Similar to its use in the pharmaceutical industry, 4-Chlorophenyl chloroformate is also utilized as an intermediate in the agrochemical sector. Its involvement in the synthesis of N-hydroxy-N-methylcarbamate 4-chlorophenyl ester makes it a crucial component in the development of agrochemical products, such as pesticides and herbicides.

Check Digit Verification of cas no

The CAS Registry Mumber 7693-45-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,6,9 and 3 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 7693-45:
(6*7)+(5*6)+(4*9)+(3*3)+(2*4)+(1*5)=130
130 % 10 = 0
So 7693-45-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H4Cl2O2/c8-5-1-3-6(4-2-5)11-7(9)10/h1-4H

7693-45-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (31175)  4-Chlorophenyl chloroformate   

  • 7693-45-0

  • 10g

  • 911.0CNY

  • Detail
  • Alfa Aesar

  • (31175)  4-Chlorophenyl chloroformate   

  • 7693-45-0

  • 50g

  • 3632.0CNY

  • Detail
  • Aldrich

  • (363871)  4-Chlorophenylchloroformate  98%

  • 7693-45-0

  • 363871-5G

  • 711.36CNY

  • Detail

7693-45-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Chlorophenyl Chloroformate

1.2 Other means of identification

Product number -
Other names (4-chlorophenyl) carbonochloridate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7693-45-0 SDS

7693-45-0Synthetic route

4-chloro-phenol
106-48-9

4-chloro-phenol

triphenylphosphine
603-35-0

triphenylphosphine

4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

Conditions
ConditionsYield
With CoCl2 In phosgene85%
4-chlorophenyl chlorothionoformate
937-64-4

4-chlorophenyl chlorothionoformate

A

4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

B

perfluoro(2,4-dimethyl-3-oxa-2,4-diazapentane)
6141-72-6

perfluoro(2,4-dimethyl-3-oxa-2,4-diazapentane)

C

C9H4ClF6NO3

C9H4ClF6NO3

D

C9H4ClF6NO2S

C9H4ClF6NO2S

Conditions
ConditionsYield
In trichlorofluoromethane for 48h; Ambient temperature;A 23%
B 12%
C 12%
D 65%
phosgene
75-44-5

phosgene

sodium 4-chlorophenolate
1193-00-6

sodium 4-chlorophenolate

4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

Conditions
ConditionsYield
In toluene; benzene for 2h; Ambient temperature;60%
phosgene
75-44-5

phosgene

antipyrine
60-80-0

antipyrine

4-chloro-phenol
106-48-9

4-chloro-phenol

4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

phosgene
75-44-5

phosgene

4-chloro-phenol
106-48-9

4-chloro-phenol

4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

Conditions
ConditionsYield
With antipyrine
With pyridine In dichloromethane at 0℃;
bis(trichloromethyl) carbonate
32315-10-9

bis(trichloromethyl) carbonate

4-chloro-phenol
106-48-9

4-chloro-phenol

4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 0 - 40℃; for 0.5h;
With triethylamine In tetrahydrofuran at 0 - 20℃; for 6.25h; Inert atmosphere;
With N,N-diethylaniline In toluene at 20℃; for 2h; Cooling with ice;
With triethylamine In dichloromethane at 0℃; for 0.5h;
4-chloro-phenol
106-48-9

4-chloro-phenol

4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 77 percent / NaH / benzene; diethyl ether / 0.5 h
2: 60 percent / benzene; toluene / 2 h / Ambient temperature
View Scheme
4-chloro-phenol
106-48-9

4-chloro-phenol

trichloromethyl chloroformate
503-38-8

trichloromethyl chloroformate

4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

Conditions
ConditionsYield
With dmap In toluene at 20℃; for 24h;
(2-fluoro-4-methoxyphenyl)hydrazine

(2-fluoro-4-methoxyphenyl)hydrazine

4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

4-chlorophenyl 2-(2-fluoro-4-methoxyphenyl)hydrazinecarboxylate
1169939-59-6

4-chlorophenyl 2-(2-fluoro-4-methoxyphenyl)hydrazinecarboxylate

Conditions
ConditionsYield
With pyridine In 1-methyl-pyrrolidin-2-one at 0 - 20℃; for 1.5h;100%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

3'-azido-2',3'-deoxythymidine
30516-87-1

3'-azido-2',3'-deoxythymidine

C17H16ClN5O6
1355331-53-1

C17H16ClN5O6

Conditions
ConditionsYield
With pyridine100%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

C2HF3O2*C13H23NO3S
400899-68-5

C2HF3O2*C13H23NO3S

C20H26ClNO5S
400899-69-6

C20H26ClNO5S

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 0℃; for 0.75h; Inert atmosphere;100%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

3, 5-dinitroaniline
618-87-1

3, 5-dinitroaniline

4-chlorophenyl 3,5-dinitrophenylcarbamate

4-chlorophenyl 3,5-dinitrophenylcarbamate

Conditions
ConditionsYield
In tetrahydrofuran at 20℃;99%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

N-Phenylhydroxylamine
100-65-2

N-Phenylhydroxylamine

N-hydroxy-N-phenylcarbamate 4-chlorophenyl ester
4645-77-6

N-hydroxy-N-phenylcarbamate 4-chlorophenyl ester

Conditions
ConditionsYield
With potassium carbonate In diethyl ether; water at 4℃;98%
With potassium carbonate In diethyl ether; water at 0 - 20℃; for 1.5h;91%
trans-4-methylaminomethyl-cyclohexanecarboxylic acid hydrochloride

trans-4-methylaminomethyl-cyclohexanecarboxylic acid hydrochloride

4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

trans-4-{[(4-chloro-phenoxy-carbonyl)-methyl-amino]-methyl}-cyclohexanecarboxylic acid

trans-4-{[(4-chloro-phenoxy-carbonyl)-methyl-amino]-methyl}-cyclohexanecarboxylic acid

Conditions
ConditionsYield
Stage #1: trans-4-methylaminomethyl-cyclohexanecarboxylic acid hydrochloride With 1,1,1,3,3,3-hexamethyl-disilazane at 140℃; for 2.5h; Heating / reflux;
Stage #2: 4-Chlorophenyl chloroformate In tetrahydrofuran at 0 - 20℃;
98%
Stage #1: trans-4-methylaminomethyl-cyclohexanecarboxylic acid hydrochloride With 1,1,1,3,3,3-hexamethyl-disilazane at 140℃; for 2.5h;
Stage #2: 4-Chlorophenyl chloroformate In tetrahydrofuran at 0 - 20℃;
98%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

C30H33N9O6

C30H33N9O6

C72H51Cl6N9O18

C72H51Cl6N9O18

Conditions
ConditionsYield
In tetrahydrofuran at 20℃;97.8%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

C78H81N21O18

C78H81N21O18

C162H117Cl12N21O42

C162H117Cl12N21O42

Conditions
ConditionsYield
In tetrahydrofuran at 20℃;97.8%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

Methyl 3,4-di-O-benzyl-2-O-para-chlorophenylcarbonyl-6-O-triisopropylsilyl-β-D-glucopyranoside
331281-71-1

Methyl 3,4-di-O-benzyl-2-O-para-chlorophenylcarbonyl-6-O-triisopropylsilyl-β-D-glucopyranoside

Methyl 3,4-di-O-benzyl-2-O-para-chlorophenylcarbonyl-6-O-triisopropylsilyl-β-D-glucopyranoside
331281-69-7

Methyl 3,4-di-O-benzyl-2-O-para-chlorophenylcarbonyl-6-O-triisopropylsilyl-β-D-glucopyranoside

Conditions
ConditionsYield
With pyridine; dmap In dichloromethane at 20℃; for 1h;96%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

N-methylhydroxyamine hydrochloride
4229-44-1

N-methylhydroxyamine hydrochloride

N-hydroxy-N-methylcarbamate 4-chlorophenyl ester
13649-16-6

N-hydroxy-N-methylcarbamate 4-chlorophenyl ester

Conditions
ConditionsYield
With potassium carbonate In diethyl ether; water96%
With potassium carbonate In diethyl ether at 20℃; for 5h;55%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

N-methylhydroxyamine hydrochloride
4229-44-1

N-methylhydroxyamine hydrochloride

potassium carbonate
584-08-7

potassium carbonate

A

4-chlorophenyl ester

4-chlorophenyl ester

B

N-hydroxy-N-methylcarbamate 4-chlorophenyl ester
13649-16-6

N-hydroxy-N-methylcarbamate 4-chlorophenyl ester

Conditions
ConditionsYield
In hexane; Dimethyl ether; waterA 96%
B n/a
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

C32H50O9
1571914-67-4

C32H50O9

C39H53ClO11

C39H53ClO11

Conditions
ConditionsYield
With pyridine; dmap In dichloromethane at 20℃; Inert atmosphere;96%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

allyl-trimethyl-silane
762-72-1

allyl-trimethyl-silane

But-3-enoic acid 4-chloro-phenyl ester
121077-72-3

But-3-enoic acid 4-chloro-phenyl ester

Conditions
ConditionsYield
With aluminium trichloride In dichloromethane for 0.5h; Ambient temperature;95%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

Methyl 2-O-allyl-3,4-di-O-benzyl-β-D-glucopyranoside
331281-66-4

Methyl 2-O-allyl-3,4-di-O-benzyl-β-D-glucopyranoside

Methyl 2-O-allyl-3,4-di-O-benzyl-6-O-para-chlorophenylcarbonyl-β-D-glucopyranoside
331281-62-0

Methyl 2-O-allyl-3,4-di-O-benzyl-6-O-para-chlorophenylcarbonyl-β-D-glucopyranoside

Conditions
ConditionsYield
With pyridine; dmap In dichloromethane at 20℃; for 1h;95%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

(Z)-3-{3,4,5-trimethoxy-2-[2-(trifluoroacetylamino)ethyl]-phenyl}prop-2-enol
1332523-83-7

(Z)-3-{3,4,5-trimethoxy-2-[2-(trifluoroacetylamino)ethyl]-phenyl}prop-2-enol

4-chlorophenyl (Z)-3-{3,4,5-trimethoxy-2-[2-(trifluoroacetylamino)ethyl]phenyl}prop-2-enyl carbonate
1332523-92-8

4-chlorophenyl (Z)-3-{3,4,5-trimethoxy-2-[2-(trifluoroacetylamino)ethyl]phenyl}prop-2-enyl carbonate

Conditions
ConditionsYield
With pyridine In dichloromethane at 0℃; for 3h; Inert atmosphere;94%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

C63H60N3O6P3*3ClH

C63H60N3O6P3*3ClH

C30H24Cl3N3O12
1083072-42-7

C30H24Cl3N3O12

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; Inert atmosphere; Cooling with ice;93%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

methyl 3,4-di-O-benzyl-2-O-levulinoyl-β-D-glucopyranoside
331281-76-6

methyl 3,4-di-O-benzyl-2-O-levulinoyl-β-D-glucopyranoside

Methyl 3,4-di-O-benzyl-6-O-para-chlorophenylcarbonyl-2-O-levulinyl-β-D-glucopyranoside

Methyl 3,4-di-O-benzyl-6-O-para-chlorophenylcarbonyl-2-O-levulinyl-β-D-glucopyranoside

Conditions
ConditionsYield
With pyridine; dmap In dichloromethane at 20℃; for 1h;91%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

4-fluoro-N-(indolin-6-yl)benzamide

4-fluoro-N-(indolin-6-yl)benzamide

4-chlorophenyl 6-(4-fluorobenzamido)indoline-1-carboxylate

4-chlorophenyl 6-(4-fluorobenzamido)indoline-1-carboxylate

Conditions
ConditionsYield
With triethylamine In acetonitrile at 60℃; under 750.075 Torr;91%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

triethyl phosphite
122-52-1

triethyl phosphite

diethyl 4-chlorophenoxycarbonylphosphonate
72305-96-5

diethyl 4-chlorophenoxycarbonylphosphonate

Conditions
ConditionsYield
90%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

ethyl 3,4,6-tri-O-benzyl-1-thio-β-D-glucopyranoside
180187-58-0

ethyl 3,4,6-tri-O-benzyl-1-thio-β-D-glucopyranoside

Thioethyl 3,4,6-tri-O-benzyl-2-O-para-chlorophenylcarbonyl-β-D-glucopyranoside
331281-74-4

Thioethyl 3,4,6-tri-O-benzyl-2-O-para-chlorophenylcarbonyl-β-D-glucopyranoside

Conditions
ConditionsYield
With pyridine; dmap In dichloromethane at 20℃; for 1h;90%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

Methyl 3,4-di-O-benzyl-2-O-para-methoxybenzyl-β-D-glucopyranoside
331281-67-5

Methyl 3,4-di-O-benzyl-2-O-para-methoxybenzyl-β-D-glucopyranoside

Methyl 3,4-di-O-benzyl-2-O-para-methoxybenzyl-6-O-para-chlorophenylcarbonyl-β-D-glucopyranoside
331281-63-1

Methyl 3,4-di-O-benzyl-2-O-para-methoxybenzyl-6-O-para-chlorophenylcarbonyl-β-D-glucopyranoside

Conditions
ConditionsYield
With pyridine; dmap In dichloromethane at 20℃; for 1h;90%
trans-4-(methylamino)cyclohexanecarboxylic acid methyl ester hydrochloride

trans-4-(methylamino)cyclohexanecarboxylic acid methyl ester hydrochloride

4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

trans-4-[(4-chloro-phenoxycarbonyl)-methyl-amino]-cyclohexane-carboxylic acid methyl ester

trans-4-[(4-chloro-phenoxycarbonyl)-methyl-amino]-cyclohexane-carboxylic acid methyl ester

Conditions
ConditionsYield
In pyridine at 0 - 20℃; for 22h;90%
(E)-2-Hexen-1-ol
928-95-0

(E)-2-Hexen-1-ol

4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

trans-hex-2-enyl 4-chlorophenyl carbonate
1419028-40-2

trans-hex-2-enyl 4-chlorophenyl carbonate

Conditions
ConditionsYield
With N,N,N,N,-tetramethylethylenediamine; triethylamine In dichloromethane at 0 - 20℃; for 0.5h;90%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

(1R,4aS,8aR)-1-((benzyloxy)methyl)octahydro-1H-pyrano[3,4-c]pyridin-7-ium chloride

(1R,4aS,8aR)-1-((benzyloxy)methyl)octahydro-1H-pyrano[3,4-c]pyridin-7-ium chloride

4-chlorophenyl (1R,4aS,8aR)-1-((benzyloxy)methyl)hexahydro-1H-pyrano[3,4-c]pyridine-7(3H)-carboxylate

4-chlorophenyl (1R,4aS,8aR)-1-((benzyloxy)methyl)hexahydro-1H-pyrano[3,4-c]pyridine-7(3H)-carboxylate

Conditions
ConditionsYield
With dmap; triethylamine In dichloromethane at 20℃; for 3h; Inert atmosphere;89%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

thymidine
50-89-5

thymidine

Carbonic acid 4-chloro-phenyl ester (2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl ester
259672-39-4

Carbonic acid 4-chloro-phenyl ester (2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl ester

Conditions
ConditionsYield
With pyridine88.3%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

2-<(methylamino)methyl>-4-nitrophenol
35039-53-3

2-<(methylamino)methyl>-4-nitrophenol

4-chlorophenyl N-(5-nitro-2-hydroxybenzyl)carbamate

4-chlorophenyl N-(5-nitro-2-hydroxybenzyl)carbamate

Conditions
ConditionsYield
With TEA In diethyl ether at 10 - 20℃; for 0.833333h;88%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

3-Phenylpropenol
104-54-1

3-Phenylpropenol

cinnamyl 4-chlorophenyl carbonate

cinnamyl 4-chlorophenyl carbonate

Conditions
ConditionsYield
With N,N,N,N,-tetramethylethylenediamine; triethylamine In dichloromethane at 0 - 20℃; for 0.5h;88%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

1-(4-phenylbutyl)-piperazine
97480-93-8

1-(4-phenylbutyl)-piperazine

4-(4-Phenylbutyl)piperazine-1-carboxylic acid 4-chlorophenyl ester
549510-70-5

4-(4-Phenylbutyl)piperazine-1-carboxylic acid 4-chlorophenyl ester

Conditions
ConditionsYield
86%
4,5-dichloro-2H-pyridazin-3-one
932-22-9

4,5-dichloro-2H-pyridazin-3-one

4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

4-chlorophenyl 4,5-dichloro-6-oxopyridazine-1(6H)-carboxylate

4-chlorophenyl 4,5-dichloro-6-oxopyridazine-1(6H)-carboxylate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 5℃; for 0.166667h;86%
4-Chlorophenyl chloroformate
7693-45-0

4-Chlorophenyl chloroformate

methyl 2-O-benzoyl-3,4-di-O-benzyl-β-D-glucopyranoside
294637-56-2

methyl 2-O-benzoyl-3,4-di-O-benzyl-β-D-glucopyranoside

Methyl 2-O-benzoyl-3,4-di-O-benzyl-6-O-para-chlorophenylcarbonyl-β-D-glucopyranoside

Methyl 2-O-benzoyl-3,4-di-O-benzyl-6-O-para-chlorophenylcarbonyl-β-D-glucopyranoside

Conditions
ConditionsYield
With pyridine; dmap In dichloromethane at 20℃; for 1h;85%

7693-45-0Relevant academic research and scientific papers

Discovery of (3-Benzyl-5-hydroxyphenyl)carbamates as new antitubercular agents with potent in vitro and in vivo efficacy

Cheng, Ya-Juan,Liu, Zhi-Yong,Liang, Hua-Ju,Fang, Cui-Ting,Zhang, Niu-Niu,Zhang, Tian-Yu,Yan, Ming

, (2019/06/07)

A series of 3-amino-5-benzylphenol derivatives were designed and synthesized. Among them, (3-benzyl-5-hydroxyphenyl)carbamates were found to exert good inhibitory activity against M. tuberculosis H37Ra, H37Rv and clinically isolated multidrug-resistant M. tuberculosis strains (MIC = 0.625-6.25 μg/mL). The privileged compounds 3i and 3l showed moderate cytotoxicity against cell line A549. Compound 3l also exhibited potent in vivo inhibitory activity on a mouse infection model via the oral administration. The results demonstrated 3-hydroxyphenylcarbamates as a class of new antitubercular agents with good potential.

Visible-Light-Induced Intramolecular C(sp2)-H Amination and Aziridination of Azidoformates via a Triplet Nitrene Pathway

Zhang, Yipin,Dong, Xunqing,Wu, Yanan,Li, Guigen,Lu, Hongjian

supporting information, p. 4838 - 4842 (2018/08/24)

Catalytic intramolecular C-H amination and aziridination reactions of o-allylphenyl azidoformates have been achieved under visible-light irradiation, providing a mild, clean, and efficient method for the synthesis of useful benzoxazolones and [5.1.0] bicyclic aziridines. Mechanistic studies suggest that a triplet nitrene acts as the reactive intermediate. The chemoselectivity of the reaction, with alkyl olefin aziridination ? electron deficient olefin aziridination ≈ C(sp2)-H amination ? C(sp3)-H amination was observed, which may be instructive in the development of an understanding of visible-light-induced triplet nitrene transformation reactions.

Evaluation of the analgesic effect of 4-anilidopiperidine scaffold containing ureas and carbamates

Monti, Ludovica,Stefanucci, Azzurra,Pieretti, Stefano,Marzoli, Francesca,Fidanza, Lorenzo,Mollica, Adriano,Mirzaie, Sako,Carradori, Simone,De Petrocellis, Luciano,Schiano Moriello, Aniello,Benyhe, Sándor,Zádor, Ferenc,Sz?cs, Edina,?tv?s, Ferenc,Erdei, Anna I.,Samavati, Reza,Dvorácskó, Szabolcs,T?mb?ly, Csaba,Novellino, Ettore

, p. 1638 - 1647 (2016/10/09)

Fentanyl is a powerful opiate analgesic typically used for the treatment of severe and chronic pain, but its prescription is strongly limited by the well-documented side-effects. Different approaches have been applied to develop strong analgesic drugs with reduced pharmacologic side-effects. One of the most promising is the design of multitarget drugs. In this paper we report the synthesis, characterization and biological evaluation of twelve new 4-anilidopiperidine (fentanyl analogues). In vivo hot-Plate test, shows a moderate antinociceptive activity for compounds OMDM585 and OMDM586, despite the weak binding affinity on both μ and δ-opioid receptors. A strong inverse agonist activity in the GTP-binding assay was revealed suggesting the involvement of alternative systems in the brain. Fatty acid amide hydrolase inhibition was evaluated, together with binding assays of cannabinoid receptors. We can conclude that compounds OMDM585 and 586 are capable to elicit antinociception due to their multitarget activity on different systems involved in pain modulation.

In vitro radical scavenging and cytotoxic activities of novel hybrid selenocarbamates

Romano, Beatriz,Plano, Daniel,Encío, Ignacio,Palop, Juan Antonio,Sanmartín, Carmen

, p. 1716 - 1727 (2015/03/30)

Novel selenocyanate and diselenide derivatives containing a carbamate moiety were synthesised and evaluated in vitro to determine their cytotoxic and radical scavenging properties. Cytotoxic activity was tested against a panel of human cell lines including CCRF-CEM (lymphoblastic leukaemia), HT-29 (colon carcinoma), HTB-54 (lung carcinoma), PC-3 (prostate carcinoma), MCF-7 (breast adenocarcinoma), 184B5 (non-malignant, mammary gland derived) and BEAS-2B (non-malignant, derived from bronchial epithelium). Most of the compounds displayed high antiproliferative activity with GI50 values below 10 μM in MCF-7, CCRF-CEM and PC-3 cells. Radical scavenging properties of the new selenocompounds were confirmed testing their ability to scavenge DPPH and ABTS radicals. Based on the activity of selenium-based glutathione peroxidases (GPxs), compounds 1a, 2e and 2h were further screened for their capacity to reduce hydrogen peroxide under thiol presence. Results suggest that compound 1a mimics GPxs activity. Cytotoxic parameters, radical scavenging activity and ADME profile point to 1a as promising drug candidate.

Synthesis and biological activity evaluation of cytidine-5′-deoxy-5- fluoro-N-[(alkoxy/aryloxy)] carbonyl-cyclic 2′,3′-carbonates

Jhansi Rani,Raghavendra,Kishore,Nanda Kumar,Hema Kumar,Jagadeeswarareddy

experimental part, p. 690 - 696 (2012/09/08)

Capecitabine, an oral prodrug of 5-FU was developed to improve the tumor selectivity and tolerability. To enhance the efficacy of capacitabine, a series of 5′-deoxy-5-fluorocytidine derivatives 5a-e were synthesized. In the present study, we investigated antitumor activity of 5′-deoxy-5- fluorocytidine derivatives both in vivo and in vitro methods. Title compounds were non-mutagenic to Salmonella typhimurium tester strain in Ames test. Compounds 5d and 5e are potent to inhibit the proliferation of NCI-69, PZ-HPV-7, MCF-7 and HeLa cells in MTT assay. In particular, 5d and 5e showed potent antitumor activities against L1210 leukemia cell line. Collectively, these findings suggest that 5d and 5e are more potent anti-cancer compounds than capecitabine.

Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands

Morera, Enrico,De Petrocellis, Luciano,Morera, Ludovica,Moriello, Aniello Schiano,Ligresti, Alessia,Nalli, Marianna,Woodward, David F.,Di Marzo, Vincenzo,Ortar, Giorgio

scheme or table, p. 6806 - 6809 (2010/06/12)

The evaluation of a series of piperazinyl carbamates and ureas, designed on the basis of previously reported TRPV1 antagonists and FAAH inhibitors, led to the identification of some 'dual-action' compounds targeting both FAAH and TRPV1 or TRPA1 receptors.

NOVEL DITHIOLOPYRROLONES AND THEIR THERAPEUTICAL APPLICATIONS

-

Page/Page column 39, (2008/06/13)

The present invention provides novel dithiolopyrrolone compounds and their salts, which promote production of white blood cells and are useful as prevention and treatments for microbial infections such as HIV infection and blood disorders such as neutropenia and other related diseases. The present invention also provides therapeutic compositions comprising particularly useful types of dithiolopyrrolones, the salts thereof, and methods and use in the manufacture of a medication for treatment of diseases.

New N-arachidonoylserotonin analogues with potential "dual" mechanism of action against pain

Ortar, Giorgio,Cascio, Maria Grazia,De Petrocellis, Luciano,Morera, Enrico,Rossi, Francesca,Schiano-Moriello, Aniello,Nalli, Marianna,De Novellis, Vito,Woodward, David F.,Maione, Sabatino,Di Marzo, Vincenzo

, p. 6554 - 6569 (2008/09/17)

N-Arachidonoylserotonin (AA-5-HT, 1a) is an inhibitor of fatty acid amide hydrolase (FAAH) that acts also as an antagonist of transient receptor potential vanilloid-type 1 (TRPV1) channels and is analgesic in rodents. We modified the chemical structure of 1a with the aim of developing "hybrid" FAAH/TRPV1 blockers more potent than the parent compound or obtaining analogues with single activity at either of the two targets to study the mechanism of the analgesic action of 1a. Thirty-eight AA-5-HT analogues, containing a serotonin "head" bound to a variety of lipophilic moieties via amide, urea, or carbamate functionalities, were synthesized. Unlike 1a, most of the new compounds possessed activity at only one of the two considered targets. The amides 1b and 1c of α- and γ-linolenic acid, however, showed "hybrid" activity similar to 1a. The carbamate 3f (OMDM106), although unable to antagonize TRPV1 receptors, was the most potent FAAH inhibitor in this study (IC50 = 0.5 μM). Compounds 3f and 1m (OMDM129), which exhibited activity at only FAAH or TRPV1, respectively, were 10-fold less potent than 1a at preventing formalin-induced hyperalgesia in mice.

Analine derivatives as OSC inhibitors

-

, (2008/06/13)

The present invention relates to compounds of formula (I) wherein U, Y, V, W, L, X, A1, A2, A3, A4, A5 and A6 are as defined in the description and claims and pharmaceutically acceptable salts and/or pharmaceutically acceptable esters thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with 2,3-oxidosqualene-lanosterol cyclase such as hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, parasite infections, gallstones, tumors and/or hyperproliferative disorders, and/or treatment and/or prophylaxis of impaired glucose tolerance and diabetes.

Heat-sensitive recording materials and phenol compounds

-

, (2008/06/13)

Heat-sensitive recording materials contain an electron-donating chromogenic compound and an electron-attracting compound. The recording materials also contain at least one compound represented by the following formula: STR1 wherein R1 and R3 mean a hydrogen atom or an alkyl, aralkyl or aryl group, R2 and R4 denote an alkyl, alkenyl, aralkyl or aryl group, X1, X2, Y1 and Y2 stand for an oxygen or a sulfur atom, and --Z1 -- and --Z2 -- are a specific aromatic group. Also provided are phenol compounds represented by the following formula: STR2 wherein R1, R2, X1 and Y1 have the same meanings as defined above; R5 and R6 are a hydrogen or halogen atom or an alkyl, alkoxy, aralkyl, aryl or hydroxyl group; p and q stand for an integer of 1-4; R5 and R6 may be either the same or different when p and q represent an integer of 2 or greater; and --Z3 -- means a specific divalent group.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 7693-45-0